Jiwoh Oh, MD, PhD

Articles

Where Tolebrutinib and Other BTK Inhibitors Fit in the MS Treatment Landscape: Jiwoh Oh, MD, PhD

March 15, 2022

The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital discussed how investigational BTK inhibitors will be used among an ever-growing MS treatment toolbox. [WATCH TIME: 3 minutes]

Overview of Tolebrutinib’s Positive 18-Month Data in Relapsing MS: Jiwoh Oh, MD, PhD

March 10, 2022

The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital provided insight on the tolebrutinib’s mechanism of action, and new data presented at ACTRIMS Forum 2022. [WATCH TIME: 4 minutes]